obesity drug glp-1 news today weight loss drugs leave users low on key nutrients, study finds Dozens of new obesity drugs

doi: 10.1007/s40259-013-0057-y 127 McCartyDColemanMBolandCL

Because weight loss is already common across NDDs, excessive or rapid GLP-1RAinduced weight loss may exacerbate frailty, potentially offsetting neurological benefits

A full one-third of the insurers higher spending was driven by high pharmaceutical outlays, and much of that was the cost and high volume of prescriptions for the blockbuster GLP-1 medications, which have long been used to treat diabetes but have become wildly popular to treat obesity

Dual Benefit: Diabetes Management and Weight Loss While not officially labeled as a weight-loss drug under the Ozempic brand, studies show that patients frequently experience significant reductions in body weight

[DOI] [PubMed] [Google Scholar] 156.Webb G.C., Akbar M.S., Zhao C., Swift H.H., Steiner D.F

Some studies show a possible link between these drugs and eye issues like NAION, but the risk is very low